Description
Title: Kortykosteroidy in the treatment of removing odd-shaped pipes
Abstract: Since they have been used for so long, corticosteroids (CS) have been the most successful treatment for people with asthma. In the majority of adult asthma patients, they are the preferred controllers. Asthma mortality, hospital admissions, asthma attack frequency, and lung function all decrease with CS. Although CS can stop irreversible airway narrowing, its effects wear off over time. Numerous cytokines involved in the inflammation associated with asthma are inhibited by CS. They reduce inflammation, but they don’t address the underlying problem. The pharmacologic characteristics of an inhaled steroid determine which one to use (receptor affinity and systemic bioavailability). There isn’t strong proof that patients with mild asthma can benefit more from regular use of an inhaled corticosteroid and long-acting b-agonist combination (LABA). It appears that using a combination of treatments when symptoms are present on occasion is the best way to manage mild asthma. In patients with moderate to severe asthma, long-term combined therapy with inhaled corticosteroid and LABA is still considered to be the “gold standard”. Patients with chronic obstructive pulmonary disease (COPD) may also use corticosteroids. CS-containing medications can lessen symptoms, but they do not change how COPD develops or progresses. Corticosteroids have no impact on all-cause mortality in COPD patients. Even at high doses, there was no evidence of inflammation suppression in COPD patients receiving oral and inhaled corticosteroids. In patients with severe disease, CS has a negligible protective effect against acute exacerbations, improving clinical outcomes and shortening hospital stays. LABA and CS combination inhalers are more efficient than either ingredient alone.
Keywords: inhaled corticosteroids, COPD, asthma
Paper Quality: SCOPUS / Web of Science Level Research Paper
Subject: Advances in Respiratory Medicine
Writer Experience: 20+ Years
Plagiarism Report: Turnitin Plagiarism Report will be less than 10%
Restriction: Only one author may purchase a single paper. The paper will then indicate that it is out of stock.
What will I get after the purchase?
A turnitin plagiarism report of less than 10% in a pdf file and a full research paper in a word document.
In case you have any questions related to this research paper, please feel free to call/ WhatsApp on +919726999915
Reviews
There are no reviews yet.